Managed Healthcare Executive November 20, 2023

Although the CDC predicted a decline in basic Medicare Part D premiums for 2024 due to the IRA, a recent report revealed an increase in premiums for Medicare Part D prescription drug plans in California, Florida, New York, Pennsylvania and Texas.

Although the Centers for Medicare & Medicaid Services (CDC) predicted a decline in basic Medicare Part D premiums for 2024 due to the Inflation Reduction Act, a recent report by HealthView Services revealed an increase in premiums for Medicare Part D prescription drug plans in California, Florida, New York, Pennsylvania and Texas.

This year’s Retirement Healthcare Costs Interim Data Report exhibited a notable rise for retirees.

With over 18 million Americans enrolled in standalone Part D plans, those opting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer
Related Articles:
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article